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Abstract
Background: The association of balanced rearrangements with breakpoints near SOX9 [SRY (sex determining
region Y)-box 9] with skeletal abnormalities has been ascribed to the presumptive altering of SOX9 expression by
the direct disruption of regulatory elements, their separation from SOX9 or the effect of juxtaposed sequences.
Case presentation: We report on two sporadic apparently balanced translocations, t(7;17)(p13;q24) and t(17;20)
(q24.3;q11.2), whose carriers have skeletal abnormalities that led to the diagnosis of acampomelic campomelic
dysplasia (ACD; MIM 114290). No pathogenic chromosomal imbalances were detected by a-CGH. The chromosome
17 breakpoints were mapped, respectively, 917–855 kb and 601–585 kb upstream of the SOX9 gene. A distal cluster
of balanced rearrangements breakpoints on chromosome 17 associated with SOX9-related skeletal disorders has
been mapped to a segment 932–789 kb upstream of SOX9. In this cluster, the breakpoint of the herein described
t(17;20) is the most telomeric to SOX9, thus allowing the redefining of the telomeric boundary of the distal
breakpoint cluster region related to skeletal disorders to 601–585 kb upstream of SOX9. Although both patients
have skeletal abnormalities, the t(7;17) carrier presents with relatively mild clinical features, whereas the t(17;20) was
detected in a boy with severe broncheomalacia, depending on mechanical ventilation. Balanced and unbalanced
rearrangements associated with disorders of sex determination led to the mapping of a regulatory region of SOX9
function on testicular differentiation to a 517–595 kb interval upstream of SOX9, in addition to TESCO (Testis-specific
enhancer of SOX9 core). As the carrier of t(17;20) has an XY sex-chromosome constitution and normal male
development for his age, the segment of chromosome 17 distal to the translocation breakpoint should contain the
regulatory elements for normal testis development.
Conclusions: These two novel translocations illustrate the clinical variability in carriers of balanced translocations
with breakpoints near SOX9. The translocation t(17;20) breakpoint provides further evidence for an additional
testis-specific SOX9 enhancer 517 to 595 kb upstream of the SOX9 gene.
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Background
The SOX9 [SRY (sex determining region Y)-box 9] gene,
mapped at 17q24.3, encodes a transcription factor with a
role in chondrogenesis [1], and also required for cellular
differentiation in heart, glial cells, neural crest progeni-
tors, notochord, pancreas, inner ear and testis [2]. Muta-
tions in the coding region of SOX9 cause campomelic
dysplasia (CD) [3]. CD is a rare and often lethal disease,
characterized by skeletal abnormalities, including short-
ening and bowing of the long bones, hypoplasia of the
scapular and pelvic bones, poor mineralization of thor-
acic pedicles, 11 pairs of ribs, and narrow iliac bones [4].
Respiratory distress, caused by small thoracic cage and
narrow airways from defective tracheobronchial carti-
lages, is the main cause of death, which occurs mostly in
the neonatal period. About 75% of CD patients with a
46,XY karyotype present disorders of sex development
with ambiguous or female external genitalia (46,XY
DSD) [4]. The abnormal curvature of long bones, the
main characteristic of CD, is absent in 10% of patients,
and the disease is then called acampomelic campomelic
dysplasia (ACD) [5]. Pierre Robin Sequence (PRS) char-
acterized by micrognathia, retroglossia, glossoptosis and
posterior cleft palate, is also a feature of CD and ACD
[6]. Although the majority of patients carry mutations in
the coding region of SOX9, balanced rearrangements
and deletions with breakpoints mapped upstream of
SOX9 have been associated with CD, ACD and PRS
[7-12]. 46,XY DSD has also been described in CD and
ACD patients who carry microdeletions and balanced
rearrangements upstream of SOX9 [8,9,11,12]. Isolated
46,XY DSD were also associated with microdeletions up-
stream of SOX9 [13,14]. Furthermore, duplications and
triplications of segments upstream of SOX9 have been
associated with isolated XX female-to-male disorder of
sex development (46,XX DSD) [13,15,16], and an appar-
ently balanced translocation with a breakpoint upstream
of SOX9 was detected in an XX male with minor skeletal
defects [17]. More distally mapped duplications up-
stream of SOX9 result in brachydactyly-anonychia [18], a
defect that is not part of the ACD-CD phenotype. The
diversity of skeletal abnormalities and DSD associated
with these balanced and unbalanced rearrangements,
extending over the 1Mb region upstream of SOX9, evi-
dences the complexity of the gene regulatory region
[19]. Adding to this, a balanced translocation in an ACD
patient [20] and a deletion in a PRS patients [10], both
mapped 3′ to SOX9, pointed to regulatory elements
located downstream of the gene.
Here we report on two ACD patients who carry appa-
rently balanced translocations, t(7;17)(p13;q24) and t(17;20)
(q24.3; q11.2). These two novel translocations further illus-
trate the variability in the severity of phenotypes associated
with breakpoints clustered upstream of SOX9. Evidence is
provided for the regulatory region critical for gonadal SOX9
expression proposed by Benko et al. [13].
Case presentation
This study was approved by the Ethic Committee for re-
search involving human subjects at the Biosciences Insti-
tute, University of São Paulo.
Patients
Patient 1
The girl, the first child of healthy non consanguineous
parents, was delivered at term after cesarean section due
to breech presentation. In the first six years of age, she
had several episodes of acute bronchitis. Her growth
chart showed her stature to be at the 50th centile until
the age of 6 years when it gradually started to fall off,
and it was around the 25th centile, at the age of 9 years.
Neuropsychomotor development was normal. At 12
years of age, she was referred to the Genetic Counseling
Service at the University of São Paulo, because of short
stature (136.5 cm, 3rd percentile), delayed bone age and
skeletal abnormalities that included hypoplastic scapulae,
thoracolumbar scoliosis, 11pairs of ribs with hypoplasia
of the first four pairs. She was prepubertal. Intellectual
development was normal. The chromosome analysis
after G-banding revealed an apparently balanced recip-
rocal translocation between the short arm of chromo-
some 7 and the long arm of chromosome 17 - t(7;17)
(p13;q24). Her parents had normal karyotypes. At 31
years of age, she returned for genetic counseling worried
about her risks of affected offspring; her height (159 cm)
and weight (54 kg) were around the 25th centile.
Patient 2
The boy, the second child of healthy non consanguin-
eous parents, was delivered at term after an uneventful
pregnancy. Birth weight was 3350 g (50th centile), length
47 cm (10th centile), and occipitofrontal circumference,
36 cm (50th centile); Apgar scores were 7, 8 and 10. The
presence of posterior cleft palate and micro/retrognathia
led to the diagnostic hypothesis of Pierre-Robin se-
quence. Scoliosis was documented by thoracic X-ray.
The boy evolved with respiratory distress, requiring oxy-
gen supplementation. At 50 days of age, he was
discharged from the hospital, but two weeks later was
readmitted with respiratory distress, pallor, and poor
general conditions, evolving with apnea and severe
bradychardia that resolved with oxygen supplementation
and chest compression. He was admitted at the ICU re-
quiring mechanical ventilation. Difficulty in weaning
from this support, led to the need of tracheostomy and
gastrostomy at 6 months of age; complementary exams
disclosed tracheobronchomalacia. Since then, the patient
has been under long-term ventilation. He evolved with
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delayed milestones, sitting up without support at 18
months of age, and walking at the age of 30 months. At
3 years of age, physical examination by one of us (DB)
showed weight of 14 kg (25-50th centile), height of 91
cm (10-25th centile) and occipitofrontal circumference
of 51 cm (50-98th centile); he had a flat facies, bilateral
epicanthus, low nasal bridge with anteverted nares,
posterior cleft palate, mild micrognathia; short neck; hy-
poplastic nipples, and severe kyphoscoliosis. He had nor-
mal male genitalia, and proportionate limbs. Speech
could not be evaluated, but he showed good social inter-
action and understanding of orders. Gradual amelior-
ation of his respiratory symptoms was recorded, but he
still needed some degree of ventilatory support. Skeletal
X-rays documented severe thoracic kyphoscoliosis, and
non-mineralized thoracic vertebral pedicles; narrow iliac
wings, delayed ischiopubic ossification, femur with flat
capital epiphysis, elongated neck, and absent lesser
trochanter; short fibula. Chromosome analysis after
G-banding revealed an apparently balanced reciprocal
translocation between the long arm of chromosome 17
and the long arm of chromosome 20 -t(17;20)(q24.3;
q11.2). His parents had normal karyotypes.
Sequencing of the SOX9 gene
As SOX9 point mutations are known to cause ACD, direct
sequencing of SOX9 coding region and intron/exon
boundaries were performed in both patients. Sequence re-
actions were performed with the BigDye Terminator v3.1
Cycle Sequencing Ready Reaction kit (Applied Biosystems,
California, USA), and analyzed on an ABI-3730 (Applied
Biosystems). No pathogenic mutations were found.
Mapping of the translocation breakpoints
Fluorescent in situ hybridization (FISH) was performed on
metaphases from cultured peripheral blood lymphocytes
with BACs selected on the University of California – Santa
Cruz – Genome Browser (UCSC; genome.ucsc.edu; hg 19;
Additional file 1: Table S1 and Additional file 2: Table S2).
Probes were labeled with biotin-14-dATP or digoxigenin-
11-dUTP by nick translation (Bio/Dig-Nick Translation
kit; Roche Diagnostics GmbH, Mannheim, Germany), and
were visualized with FITC- or rhodamine-conjugated anti-
bodies, chromosomes being counterstained with 4,6-
diamidine-2-phenylindole (DAPI) in VectaShield Mount-
ing Medium (Vector Laboratories, Burlingame, CA, USA).
Chromosomal micro imbalances were investigated by
array-comparative genomic hybridization (a-CGH) using
the Agilent Human Genome 105A CGH Microarray
(Agilent Technologies Inc., Santa Clara, CA, USA). The
microarray chip was scanned on an Agilent Microarray
Scanner. The data were processed by Agilent Feature Ex-
traction software 9.5 and analyzed with Agilent CGH Ana-
lytics 3.4 Software with the statistical algorithm ADM-2,
and sensitivity threshold 6.7. At least three consecutive oli-
gonucleotides had to have aberrant log2 ratios to be called
by the software.
Patient 1 – t(7;17)
On chromosome 7, the breakpoint was mapped within
a ~53 kb interval (chr7:43,130,626-43,183,638; Human
GRCh37 assembly, hg19) (Figure 1A and Additional file 1:
Table S1). The gene HECW1 (HECT, C2 and WW domain
containing E3 ubiquitin protein ligase 1), which is
expressed especially in brain and skeletal muscle, is par-
tially mapped to this interval and might have been
interrupted by the breakpoint. On chromosome 17, the
breakpoint was mapped to a ~62 kb segment (chr17:
69,201,539-69,262,086), a gene desert region (Figure 1B
and Additional file 1: Table S1). No potentially pathogenic
chromosomal imbalances were detected by a-CGH.
Patient 2 – t(17;20)
On chromosome 17 the breakpoint was mapped to a ~16
kb segment (chr17: 69,516,104-69,531,685), a gene desert
region (Figure 2A and Additional file 2: Table S2). On
chromosome 20, the breakpoint was mapped within a ~50
kb interval (chr20: 34,832,526-34,883,260) (Figure 2B and
Additional file 2: Table S2). The C20orf4 (chromosome 20
open reading frame 4) is mapped to this interval and
might have been interrupted by the breakpoint. No poten-
tially pathogenic chromosomal imbalances were detected
by a-CGH.
Discussion
Here we describe two carriers of apparently balanced trans-
locations with breakpoints at 17q24.3. Both patients had
skeletal defects that led to the diagnosis of acampomelic
campomelic dysplasia (ACD). The breakpoints of the
t(7:17)(p13;q24) and t(17;20)(q24.3;q11.2) translocations
were mapped on chromosome 17, respectively, 855-917 kb
and 585–601 kb upstream of SOX9. These translocations
caused the clinical phenotypes by presumptively altering
SOX9 expression, as other previously described balanced
rearrangements upstream of SOX9 associated with skeletal
defects (Figure 3 and Table 1). Based on the clinical presen-
tation of carriers and the distance of breakpoints from the
SOX9 coding sequence, these balanced rearrangements
were grouped in three clusters - “proximal”, “distal” and
“PRS” [9,10,19]. Breakpoints of balanced rearrangements
mapped 50–375 kb and 789–932 kb upstream of the SOX9
coding sequence, were grouped, respectively, into the prox-
imal and distal clusters [9]. These balanced rearrangements
were detected in CD and ACD patients. In addition, a third
clustering of balanced rearrangements, associated with the
Pierre Robin Sequence (PRS), mapped 1.03-1.26Mb up-
stream of SOX9, [10]. Accordingly, the translocations here
described should be included in the distal cluster mapped
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Figure 1 Analysis of the t(7;17) breakpoint regions on chromosomes 7 and 17. (A) Chromosome 7 clone RP11-256F18 yielded FISH signals
on the normal 7 and on the der(17). Clone RP5-1032B10 produced FISH signals on the normal 7 and on the der(7). The 53 kb segment
(chr7:43,130,626-43,183,638) between these clones contains the chromosome 7 breakpoint. The HECW1 gene, partially mapped to this interval,
is depicted. (B) Chromosome 17 clones RP11-1087C16 and RP11-261A13 produced FISH signals on the normal 17 and on both the der(7) and
the der(17); the weaker signal of RP11-1087C16 on the der(7) suggests that the breakpoint occurred at the distal end of this clone. Clone RP11-
433D1 yielded FISH signals on the normal 17 and on the der(7). The 62 kb segment of overlap between clones RP11-1087C16 and RP11-261A1,
delimited by the sequence of clone RP11-1087C16 that does not overlap with clone RP11-433D1, contains the translocation breakpoint
(chr17: 69,201,539-69,262,086). (Based on UCSC Genome Bioinformatics, hg19).
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Figure 2 Analysis of the t(17;20) breakpoint regions on the 17 and 20 chromosomes. (A) Chromosome 17 clone RP11-281D8 yielded FISH
signals on the normal chromosome 17 and on the der(17) (arrows).Clones RP11-474K15 and RP11-203M16 produced FISH signals on the normal
chromosome 17 and on both derivative chromosomes, der(17) and der(20) (arrows); the stronger signal of RP11-474K15 on the der(17) suggests
that the breakpoint occurred on the distal end of this clone. Clone RP11-134J16 yielded FISH signals on the normal chromosome 17 and on the
der(20) (arrows). Cross hybridization signals were produced by clones RP11-281D8 (on the short arms of chromosomes 17), RP11-203M16 and
RP11-134J16 [on the short arms of chromosomes 20 and der(20)], and RP11-281D8 [on the short arms of chromosomes 17 and der(17)]. The 15
kb segment, overlapped by clones RP11-474K15 and RP11-203M16 and delimited by the sequence between clones RP11-281D8 and RP11-134J16,
contains the chromosome 17 breakpoint (chr17: 69,516,104-69,531,685). (B) Chromosome 20 clones RP11-10K23 (red) and RP11-369K4 (green)
produced FISH signals on the normal chromosome 20 and on the der(20). Clone RP11-234K24 produced FISH signals on the normal
chromosome 20 and on both derivative chromosomes, der(17) and der(20); the stronger signal of clone RP11-234K24 on the der(20) suggests
that the breakpoint occurred on the distal end of the clone. The 50 kb segment of clone RP11-234K24, delimited by the sequence of clone
RP11-234K24 that does not overlap with clones RP11-10K23 and RP11-369K4, contains the translocation breakpoint (chr20: 34,832,526-34,883,260).
(Based on UCSC Genome Bioinformatics, hg19).
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789–932 kb upstream of SOX9. The translocation t(17;20)
breakpoint, however, is more proximal to SOX9, thus
allowing the redefining of the telomeric boundary of the
distal cluster of breakpoints to 585–601 kb upstream of
SOX9.
The spectrum of phenotypes associated with SOX9
presumptive misregulation provides insights into the
gene regulatory region. As opposed to carriers of SOX9
point mutations, who usually die in the neonatal period
[4], carriers of balanced rearrangements tend to have
longer life expectancy (Table 1), an indication that bal-
anced rearrangements that presumptively modify SOX9
expression generally do not impact SOX9 expression to
the same extent as the inactivation of one SOX9 allele by
point mutations. However, balanced rearrangements
with breakpoints in the proximal and distal clusters are
associated with CD and ACD, thus indicating that
breakpoints mapped 50 kb to 932 kb upstream of SOX9
modify its expression in craniofacial structures, scapulae,
ribs, vertebrae and limbs. The disruption of regulatory
elements by breakpoints or their separation from SOX9
might have altered the gene spatial/temporal expression
in carriers of these balanced rearrangements. In fact, the
segment 350 kb upstream of the gene contains several
SOX9 putative regulatory elements [21,28] (Figure 3).
Nine out of the 12 balanced rearrangements in the prox-
imal cluster were detected in CD patients with mild
(three cases) or severe (six cases) bowing of long bones
Figure 3 Chromosomal rearrangements upstream of SOX9 presumptively associated with SOX9 misregulation. Balanced and unbalanced
rearrangements with breakpoints mapped upstream of SOX9, detected in patients with campomelic dysplasia (CD; blue), acampomelic campomelic
dysplasia (ACD; red), Pierre Robin Sequence (PRS; green), minor or no skeletal defects (gray) and brachydactyly-anonychia (black) are shown. The
centromeric limit of the two deletions represented by arrows extends beyond the region shown. SOX9 and other nearby genes are depicted. The
breakpoints of balanced rearrangements are grouped into proximal, distal and PRS breakpoint clusters, according to their distance from SOX9; the
herein described t(17;20) redefines the telomeric boundary of the distal cluster (see Table 1 for details). Disorders of sex development (DSD) are
indicated: XY SDS (black circle symbol) and XX SDS (black triangle symbol). SOX9 regulatory elements E1 and E2 [21], TESCO [22], and E3 [10]
are shown in the upper part of the figure (black oval symbol). The candidate region for the TESTIS-SPECIFIC ENHANCER [13], represented by the
vertical bar, is spanned by all deletions and duplications detected in patients with DSD. (Based on UCSC Genome Bioinformatics, hg19).
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Table 1 Chromosome 17 balanced rearrangements and deletions in patients with campomelic dysplasia (CD), acampomelic campomelic dysplasia (ACD) and
Pierre-Robin sequence (PRS)
Rearrangements Inheritance Breakpoint distance from SOX9 (kb) Breakpoint
cluster
Phenotype Sex Survival time Reference
5′ 3′
t(7;17)(q34;q25.1) Sporadic 50 Proximal CD (Severe campomelia) F* >6 years [23,24]
t(12;17)(q21.32;q24.3-q25.1) Sporadic 74–88 Proximal ACD F* 11 months (diseased) [25,26]
t(2;17)(q35;q23-q24) Sporadic 88 Proximal CD (Severe campomelia) F* Abortion [3,27]
t(9;17) Sporadic 110–140 Proximal CD (Severe campomelia) M >3 years [28]
t(13;17)(q22;q25.1) Sporadic 134–142 Proximal ACD F* >30 years [7,23,29]
t(1;17)(q42.13;q24.3-q25.1) Sporadic 173–179 Proximal CD (Severe campomelia) F >6 years [7,23,29]
t(5;17)(q23.2;q24) Sporadic 161 Proximal ACD ? ? [30]
t(6;17)(q14;q24) Sporadic 212–224 Proximal CD (Mild campomelia) F* >3 years [7,29]
t(10;17)(q24;q23) Sporadic 228–229 Proximal CD (Severe campomelia) (M) >1 year [7]
t(5;17)(q13.3;q24.2) Sporadic 288–319 Proximal CD (Severe campomelia) F >12 years [7]
inv(17)(q11.2;q24.3-q25.1) Sporadic 70–350 Proximal CD (Mild campomelia) F* >2 years [4,28]
t(1;17) (q42.1;q24.3) Sporadic 375 Proximal CD (Mild campomelia) (M) >5 years [9]
del(17)(q24.3) Sporadic 380-1.869 ACD F* >5 years [8]
del(17)(q24.3) Familial 517-1.477 ACD F* > 3 and 32 years [11]
t(7;17)(q33;q24)del(17)(q24.2q24.3) Sporadic 500-4700 ACD F* ? [12]
t(17;20)(q24.3;q11.2) Sporadic 585-601 Distal ACD M >3 years Present study
t(12;17)(q14.3;q24.3) Sporadic 776-811 Distal Mandibular and malar hypoplasia M* > Newborn [17]
t(Y;17)(q11.2;q24.3) Sporadic 789 Distal ACD F* >3 years [9]
t(7;17)(p.13;q24) Sporadic 855-917 Distal ACD F >32 years Present study
t(4;17)(q28.3;q24.3) Familial 899 Distal ACD F /M > 6 and 32 years [20]
t(13;17)(q22.1;q22.3) Familial 932 Distal ACD F/ M ? [31]
t(17;22)(q25.1;p11.2) Sporadic 900 Distal ACD {M} 6 years (diseased) [7,31]
t(5;17)(q15;q24) Familial 1030-1100 PRS PRS F/M ? [10]
t(2;17)(q32;q24) Familial 1160-1200 PRS PRS F/M ? [10]
inv(17)(q21.31q24.3)del(17)(q24.3q23) Sporadic 1160-1460 PRS M >1 year [32]
t(2;17)(q24.1;q24.3) Familial 1230 PRS PRS F /M ? [10]
del(17)(q24.3) Familial 1380-1450 PRS F /M ? [10]
del(17)(q24.3) Sporadic 1580-1890 PRS ? ? [10]
t(4;7;8;17) Sporadic 1300 ACD F* 3 weeks (diseased) [20]
del(17)(q25.1) Sporadic 1520-1560 PRS ? ? [10]
CD Campomelic Dysplasia, ACD Acampomelic Campomelic Dysplasia, PRS Pierre Robin Sequence, DSD Disorder of Sex Development.
M Male, (M) Male with hypospadias {M}, Male with small penis M*, 46, XX DSD, F Female XX, F*, 46,XY DSD.
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(Table 1). On the other hand, the seven balanced trans-
locations in the distal cluster, including the two novel
translocations we describe here, were detected in ACD
patients; the exception was a translocation t(12;17) in a
patient whose osseous anomalies consisted only of man-
dibular and malar hypoplasia, and a dysplastic 12th pair
of ribs [17] (Table 1). The translocations in this distal
cluster would have impacted SOX9 more distally located
regulatory elements, the more proximal ones remaining
in cis to SOX9, thus resulting in straight long bones. The
PRS cluster points to regulatory elements located more
than 1Mb upstream of SOX9 that would control its ex-
pression in craniofacial structures; alternatively, these
could also be general enhancers affecting only craniofa-
cial structures due to its sensitivity to SOX9 levels [19].
The three reported translocations in the PRS cluster
would have affected only the SOX9 more distally located
regulatory elements, and the rest of the gene regulatory
region would have remained intact.
Large deletions upstream of SOX9, which remove the
PRS and distal clusters, were detected in patients with a
mild ACD phenotype [8,11,12] similar to that manifested
by carriers of balanced translocations with the most dis-
tally located breakpoints in the distal cluster– t(13;17)
[31], t(4;17) [20], and t(7;17) here described (Table 1 and
Figure 3). These rearrangements would have affected the
same regulatory element(s). Deletions mapped more than
1Mb upstream of SOX9 result in PRS [10,32]. Likewise,
these deletions would have impacted the same regulatory
element(s) as balanced translocations in the PRS cluster.
In addition to isolating the SOX9 from cis regulatory
elements or disrupting these elements, the chromosomal
rearrangements might impact SOX9 expression through a
position effect that would explain the phenotype variability
of carriers of rearrangements with breakpoints mapped to
the same cluster. For instance, the carriers of three ba-
lanced translocations in the distal cluster had severe forms
of ACD (Figure 3). A patient whose translocation break-
point mapped 900 kb upstream of SOX9 died at the age of
6 years consequent to tracheobronchomalacia [7]; the car-
rier of a translocation with a breakpoint 789 kb from SOX9
also suffered from severe respiratory distress in early in-
fancy [9], and the herein described carrier of the t(17;20)
with a breakpoint 585–601 kb from SOX9 had severe
tracheobroncheomalacia and remained hospitalized on the
dependence of mechanical ventilation for proper mainten-
ance of oxygen saturation. The chromosome 17 break-
point of the two previously published translocations were
mapped to close proximity of those of balanced translo-
cations in patients with milder phenotypes, including fa-
milial cases (Figure 3; Table 1). The authors proposed
that the translocation of SOX9 gene to heterochromatic
regions or its proximity would have resulted in reduction
of expression/silencing of the gene. Similarly, the severe
phenotype of the carrier of the t(17;20) here described
might have resulted from the effect of chromosome 20
sequences on SOX9 expression.
SOX9 has a role in sex determination. A SOX9 testis-
specific enhancer, TESCO (Testis-specific Enhancer of
SOX9 Core), was mapped 10–15 kb upstream of SOX9
[22] (Figure 3). However, deletions upstream of SOX9 in
patients with 46,XY DSD [8,11-14], as well as duplica-
tions upstream of SOX9 in patients with 46,XX DSD
[13,15,16,33] do not include TESCO (Figure 3), thus
pointing to a second testis-specific enhancer located
517–595 kb upstream of SOX9 [13]. Loss of this region
in deletion carriers resulted in 46,XY DSD, despite the
presence of an intact SRY gene [8,11-14]. The high ex-
pression of SOX9 would lead to the testicular differenti-
ation in XX males carrying duplication of this region
[13,15,16,33]. As the carrier of t(17;20) here described
has an XY sex-chromosome constitution and normal
male development for his age, the segment of chromo-
some 17 distal to the translocation breakpoint should
contain the regulatory elements necessary for normal
testis development, and was translocated to chromo-
some 20 together with SOX9. Thus this translocation
breakpoint provides further evidence of a cis-acting
testis-specific enhancer located 517 to 585–595 kb up-
stream of SOX9. The isolating of this testis-specific po-
tential enhancer from SOX9 would explain why the
great majority of balanced rearrangements in the prox-
imal cluster, which do not affect TESCO, result in XY
DSD or XY males with hypospadia (Table 1; Figure 3).
However, two balanced translocations with breakpoints
in the distal cluster - the t(Y; 17), carried by an XY fe-
male [9] and the t(12;17), carried by an XX male [17], are
mapped centromeric to this putative testis specific enhan-
cer (Figure 3). In these two cases, a position effect of the Y
heterochromatic block and of chromosome 12 sequences,
respectively, would have reduced or increased SOX9 ex-
pression, thus leading to female and male phenotypes, re-
spectively. The low and high level of SOX9 expression,
respectively, would also explain the severe and mild ske-
letal abnormalities in these two patients [9,17].
Conclusions
The novel translocations t(7;17) and t(17;20) herein de-
scribed illustrate the clinical variability in carriers of bal-
anced translocations with breakpoints near SOX9. Taken
together, the rearrangements affecting segments in the
vicinity of SOX9 point to a regulatory region that control
skeletal development possibly extending beyond the 1Mb
region upstream of SOX9, and to a regulatory region of
sex determination, in addition to TESCO, located 517–
595 kb upstream of SOX9. The breakpoint of the herein
described t(17;20) allowed to redefine the telomeric
boundary of the distal breakpoint of the cluster region
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related to skeletal defects to 601–585 kb upstream of
SOX9. The translocation t(17;20) breakpoint also provides
further evidence for an additional testis-specific SOX9 en-
hancer 517 to 595 kb upstream of the SOX9 gene.
Consent
Written informed consent was obtained from the patient
or parents for publication of this clinical data and any
accompanying images.
Additional files
Additional file 1: Table S1. BAC clones used as probes for
chromosome 7 and 17 breakpoint mapping in Patient 1.
Additional file 2: Table S2. BAC and PAC clones used as probes for
chromosome 17 and 20 breakpoint mapping in Patient 2.
Abbreviations
SOX9: [SRY (sex determining region Y)-box 9] gene; CD: Campomelic
campomelic dysplasia; DSD: Disorders of sex development;
ACD: Acampomelic campomelic dysplasia; PRS: Pierre Robin Sequence;
TESCO: (Testis-specific enhancer of SOX9 core) region.
Competing interest
None of the authors have any conflict of interest to disclose.
Authors’ contributions
All authors made substantive intellectual contributions to the study and
have given final approval to the manuscript. Additionally, specific author’s
contributions are as follows: ACSF participated in the design of the study,
performed and analyzed FISH and a-CGH data, drafted the manuscript, and
finalized it. AB participated in the analysis of the molecular data, DRB, PAO
and CAK acquired and interpreted clinical data. AMVM conceived the study,
participated in its design and coordination, drafted the manuscript and
finalized it. All authors read and approved the final manuscript.
Acknowledgements
This work was funded by FAPESP - Fundação de Amparo à Pesquisa do
Estado de São Paulo (Grants: CEPID-Human Genome Study Center 98/14254-
2; and student fellowships 2009/03480-8, 2011/14293-4 and 2011/12486-0).
Author details
1Departamento de Genética e Biologia Evolutiva, Instituto de Biociências,
Universidade de São Paulo, Rua do Matão, 277, São Paulo, SP 05508-090,
Brazil. 2Unidade de Genética, Instituto da Criança, HC/FMUSP, São Paulo, SP,
Brazil.
Received: 12 December 2012 Accepted: 23 April 2013
Published: 7 May 2013
References
1. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B: The
transcription factor Sox9 has essential roles in successive steps of the
chondrocyte differentiation pathway and is required for expression of
Sox5 and Sox6. Genes Dev 2002, 16:2813–2828.
2. Pritchett J, Athwal V, Roberts N, Hanley NA, Hanley KP: Understanding the
role of SOX9 in acquired diseases: lessons from development. Trends Mol
Med 2011, 17:166–174.
3. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic
M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, Brook JD, Schafer
AJ: Campomelic dysplasia and autosomal sex reversal caused by
mutations in an SRY-related gene. Nature 1994, 372:525–530.
4. Mansour S, Hall CM, Pembrey ME, Young ID: A clinical and genetic study
of campomelic dysplasia. J Med Genet 1995, 32:415–420.
5. Moog U, Jansen NJ, Scherer G, Schrander Stumpel CT: Acampomelic
campomelic syndrome. Am J Med Genet 2001, 104:239–245.
6. Holder-Espinasse M, Abadie V, Cormier-Daire V, Beyler C, Manach Y,
Munnich A, Lyonnet S, Couly G, Amiel J: Pierre Robin sequence: a series of
117 consecutive cases. J Pediatr 2001, 139:588–590.
7. Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, Birren B, Korniszewski L, Back
E, Scherer G: Campomelic dysplasia translocation breakpoints are
scattered over 1 Mb proximal to SOX9: evidence for an extended control
region. Am J Hum Genet 1999, 65:111–124.
8. Pop R, Conz C, Lindenberg KS, Blesson S, Schmalenberger B, Briault S, Pfeifer
D, Scherer G: Screening of the 1 Mb SOX9 5′ control region by array CGH
identifies a large deletion in a case of campomelic dysplasia with XY sex
reversal. J Med Genet 2004, 41:e47.
9. Leipoldt M, Erdel M, Bien-Willner GA, Smyk M, Theurl M, Yatsenko SA, Lupski
JR, Lane AH, Shanske AL, Stankiewicz P, Scherer G: Two novel translocation
breakpoints upstream of SOX9 define borders of the proximal and distal
breakpoint cluster region in campomelic dysplasia. Clin Genet 2007,
71:67–75.
10. Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, Ramsay J, Jamshidi N,
Essafi A, Heaney S, Gordon CT, McBride D, Golzio C, Fisher M, Perry P,
Abadie V, Ayuso C, Holder-Espinasse M, Kilpatrick N, Lees MM, Picard A,
Temple IK, Thomas P, Vazquez MP, Vekemans M, RoestCrollius H, Hastie ND,
Munnich A, Etchevers HC, Pelet A, Farlie PG, Fitzpatrick DR, Lyonnet S:
Highly conserved non-coding elements on either side of SOX9
associated with Pierre Robin sequence. Nat Genet 2009, 41:359–364.
11. Lecointre C, Pichon O, Hamel A, Heloury Y, Michel-Calemard L, Morel Y,
David A, Le Caignec C: Familial acampomelic form of campomelic
dysplasia caused by a 960 kb deletion upstream of SOX9. Am J Med
Genet 2009, 149A:1183–1189.
12. Jakubiczka S, Schröder C, Ullmann R, Volleth M, Ledig S, Gilberg E, Kroisel P,
Wieacker P: Translocation and deletion around SOX9 in a patient with
acampomelic campomelic dysplasia and sex reversal. Sex Dev 2010,
4:143–149.
13. Benko S, Gordon CT, Mallet D, Sreenivasan R, Thauvin-Robinet C,
Brendehaug A, Thomas S, Bruland O, David M, Nicolino M, Labalme A,
Sanlaville D, Callier P, Malan V, Huet F, Molven A, Dijoud F, Munnich A,
Faivre L, Amiel J, Harley V, Houge G, Morel Y, Lyonnet S: Disruption of a
long distance regulatory region upstream of SOX9 in isolated disorders
of sex development. J Med Genet 2011, 48:825–830.
14. White S, Ohnesorg T, Notini A, Roeszler K, Hewitt J, Daggag H, Smith C,
Turbitt E, Gustin S, van den Bergen J, Miles D, Western P, Arboleda V,
Schumacher V, Gordon L, Bell K, Bengtsson H, Speed T, Hutson J, Warne G,
Harley V, Koopman P, Vilain E, Sinclair A: Copy number variation in
patients with disorders of sex development due to 46,XY gonadal
dysgenesis. PLoS One 2011, 6:e17793.
15. Cox JJ, Willatt L, Homfray T, Woods CG: A SOX9 duplication and familial
46, XX developmental testicular disorder. N Engl J Med 2011, 364:91–93.
16. Vetro A, Ciccone R, Giorda R, Patricelli MG, Della Mina E, Forlino A, Zuffardi
O: XX males SRY negative: a confirmed cause of infertility. J Med Genet
2011, 48:710–712.
17. Refai O, Friedman A, Terry L, Jewett T, Pearlman A, Perle MA, Ostrer H:
De novo 12;17 translocation upstream of SOX9 resulting in 46, XX testicular
disorder of sex development. Am J Med Genet 2010, 152A:422–426.
18. Kurth I, Klopocki E, Stricker S, van Oosterwijk J, Vanek S, Altmann J, Santos
HG, van Harssel JJ, de Ravel T, Wilkie AO, Gal A, Mundlos S: Duplications of
noncoding elements 5′ of SOX9 are associated with brachydactyly-
anonychia. Nat Genet 2009, 2009(41):862–863.
19. Gordon CT, Tan TY, Benko S, Fitzpatrick D, Lyonnet S, Farlie PG: Long-range
regulation at the SOX9 locus in development and disease. J Med Genet
2009, 46:649–656.
20. Velagaleti GV, Bien-Willner GA, Northup JK, Lockhart LH, Hawkins JC, Jalal
SM, Withers M, Lupski JR, Stankiewicz P: Position effects due to
chromosome breakpoints that map approximately 900 Kb upstream and
approximately 1.3 Mb downstream of SOX9 in two individuals with
campomelic dysplasia. Am J Hum Genet 2005, 76:652–662.
21. Bagheri-Fam S, Barrionuevo F, Dohrmann U, Gunther T, Schule R, Kemler R,
Mallo M, Kanzler B, Scherer G: Long-range upstream and downstream
enhancers control distinct subsets of the complex spatiotemporal Sox9
expression pattern. Dev Biol 2006, 291:382–397.
22. Sekido R, Lovell-Badge R: Sex determination involves synergistic action of
SRY and SF1 on a specific Sox9 enhancer. Nature 2008, 453:930–934.
23. Tommerup N, Schempp W, Meinecke P, Pedersen S, Bolund L, Brandt C,
Goodpasture C, Guldberg P, Held KR, Reinwein H, Saugstad OD, Scherer G,
Fonseca et al. BMC Medical Genetics 2013, 14:50 Page 9 of 10
http://www.biomedcentral.com/1471-2350/14/50
Skjeldal O, Toder R, Westvik J, van der Hagen CB, Wolf U: Assignment of an
autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1)
to 17q24.3-q25.1. Nat Genet 1993, 4:170–174.
24. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli
FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Scherer G:
Autosomal sex reversal and campomelic dysplasia are caused by
mutations in and around the SRY-related gene SOX9. Cell 1994,
79:1111–1120.
25. Ninomiya S, Narahara K, Tsuji K, Yokoyama Y, Ito S, Seino Y: Acampomelic
campomelic syndrome and sex reversal associated with de novo t(12;17)
translocation. Am J Med Genet 1995, 56:31–34.
26. Ninomiya S, Isomura M, Narahara K, Seino Y, Nakamura Y: Isolation of a
testis-specific cDNA on chromosome 17q from a region adjacent to the
breakpoint of t(12;17) observed in a patient with
acampomeliccampomelic dysplasia and sex reversal. Hum Mol Genet
1996, 5:69–72.
27. Young ID, Zuccollo JM, Maltby EL, Broderick NJ: Campomelic dysplasia
associated with a de novo 2q;17q reciprocal translocation. J Med Genet
1992, 29:251–252.
28. Wunderle VM, Critcher R, Hastie N, Goodfellow PN, Schedl A: Deletion of
longrange regulatory elements upstream of SOX9 causes campomelic
dysplasia. Proc Natl Acad Sci USA 1998, 95:10649–10654.
29. Wirth J, Wagner T, Meyer J, Pfeiffer RA, Tietze HU, Schempp W, Scherer G:
Translocation breakpoints in three patients with campomelic dysplasia
and autosomal sex reversal map more than 130 kb from SOX9. Hum
Genet 1996, 97:186–193.
30. Sobreira NL, Gnanakkan V, Walsh M, Marosy B, Wohler E, Thomas G, Hoover-
Fong JE, Hamosh A, Wheelan SJ, Valle D: Characterization of complex
chromosomal rearrangements by targeted capture and next-generation
sequencing. Genome Res 2011, 21:1720–1727.
31. Hill-Harfe KL, Kaplan L, Stalker HJ, Zori RT, Pop R, Scherer G, Wallace MR:
Fine mapping of chromosome 17 translocation breakpoints > or = 900
kb upstream of SOX9 in acampomelic campomelic dysplasia and a mild,
familial skeletal dysplasia. Am J Hum Genet 2005, 76:663–671.
32. Fukami M, Tsuchiya T, Takada S, Kanbara A, Asahara H, Igarashi A, Kamiyama
Y, Nishimura G, Ogata T: Complex genomic rearrangement in the SOX9 5′
region in a patient with Pierre Robin sequence and hypoplastic left
scapula. Am J Med Genet 2012, 158A:1529–1534.
33. Huang B, Wang S, Ning Y, Lamb AN, Bartley J: Autosomal XX sex reversal
caused by duplication of SOX9. Am J Med Genet 1999, 87:349–353.
doi:10.1186/1471-2350-14-50
Cite this article as: Fonseca et al.: The clinical impact of chromosomal
rearrangements with breakpoints upstream of the SOX9 gene: two
novel de novo balanced translocations associated with acampomelic
campomelic dysplasia. BMC Medical Genetics 2013 14:50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fonseca et al. BMC Medical Genetics 2013, 14:50 Page 10 of 10
http://www.biomedcentral.com/1471-2350/14/50
